Subscribe to An evaluation of early use patterns to assess the effectiveness of Xeljanz® (tofacitinib citrate) in rheumatoid arthritis: A retrospective non-interventional database study of observational data embedded within Optimising Patient outcome in Australian RheumatoLogy - Quality Use of Medicines Initiative (OPAL-QUMI) (OPal study of xeljanz Effectiveness in RA - OPERA)